4C Medical Technologies, Inc.
PrivateLast Round
Series D
Mar 5, 2025
Total Funding Raised
$254.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
4C Medical Technologies, Inc. is a medical device company that develops minimally invasive therapies for structural heart disease, specifically focusing on the treatment of mitral regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4C Medical Technologies, Inc. Comparables
Compare 4C Medical Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HighLife Medical | 88% | |
| Polares Medical | 88% | |
| Tioga Cardiovascular | 87% |
4C Medical Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 5, 2025 | ||||
| Series C | Mar 31, 2022 | ||||
| Convertible Debt | Dec 22, 2020 | ||||
| Series B | Oct 2, 2019 | ||||
| Series A | Sep 10, 2018 | ||||
Convertible Debt | Jul 19, 2017 |
Key People
Founding team and executive leadership
4C Medical Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AG Collective Capital | Series D |
| MicroPort CardioFlow Medtech Corporation | Series D, Series A, Series C |
| Boston Scientific Corporation | Series D |
| Yonghua Capital | Convertible Debt |
| Anges Quebec | Convertible Debt |
| Boston Scientific Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 42% MoM, reaching 2.3K.
- Mar 5, 2025
$175M round led by Boston Scientific Corporation and Cortex, Inc.
4C Medical Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about 4C Medical Technologies, Inc.'s valuation, stock price, and market status.
Is 4C Medical a public or private company?
4C Medical is a private company.
What is the current stock price of 4C Medical?
4C Medical is a private company with no public stock price. No recent secondary market data is available.
How much is 4C Medical worth (valuation)?
Valuation information for 4C Medical is not publicly available.
Can I buy 4C Medical stock?
4C Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was 4C Medical's last funding round?
4C Medical's most recent funding round was Series D on March 5, 2025.
Who are the main investors in 4C Medical?
Key investors in 4C Medical include MicroPort CardioFlow Medtech Corporation, Boston Scientific Corporation, Anges Quebec.
Will 4C Medical IPO soon?
No public IPO plans have been announced for 4C Medical.
How can I track 4C Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 4C Medical's secondary market activity and sign up for updates.